ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Weatherford shareholders approve move to Delaware from Ireland

Re-domiciliation expected to generate $20-30 million in annual cash savings by 2027 as Weatherford shifts legal base to U.S. state. Deal subject to Irish High Court approval in Q4 2026.

PA
Priya Anand · Equities & Earnings Desk · 3 Sept 2026 · 23:28 · 1 min read
Share
Weatherford shareholders approve move to Delaware from Ireland

Shareholders of Weatherford International plc approved a proposal to re-domicile the company from Ireland to Delaware, a move aimed at simplifying its corporate structure and supporting future growth.

The approval, granted at both the Scheme Meeting convened by the board and the Extraordinary General Meeting, paves the way for the transition to take effect in the fourth quarter of 2026, subject to customary closing conditions, including final approval from the High Court of Ireland.

The company expects the re-domiciliation to deliver annual cash savings of approximately $20 million to $30 million starting in 2027, while providing a more streamlined regulatory and statutory framework. Weatherford’s CEO Girish Saligram highlighted the shareholder support as a validation of the company’s long-term strategy.

Weatherford, which operates energy services across six continents, provides drilling, well construction, and production solutions throughout the life cycle of wells. The move to Delaware is intended to enhance the company’s corporate governance and cash flow conversion, according to Saligram.

The company’s shares closed at $94.54 on September 1, down 3.30% from the previous session, as the market digested the announcement.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT